ContractEnablex Agreement • January 23rd, 2009 • BMP Sunstone CORP • Wholesale-drugs, proprietaries & druggists' sundries
Contract Type FiledJanuary 23rd, 2009 Company Industry* Certain information in this exhibit has been omitted and will be filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request under 17 C.F.R. Sections 200.80(b)(4), 200.83 and 230.406.
ContractEnablex Agreement • May 7th, 2008 • BMP Sunstone CORP • Wholesale-drugs, proprietaries & druggists' sundries
Contract Type FiledMay 7th, 2008 Company Industry* Certain information in this exhibit has been omitted and will be filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request under 17 C.F.R. Sections 200.80(b)(4), 200.83 and 230.406.
Enablex Agreement Between Shanghai Novartis Trading Co., Ltd No 27, Huashen Road, Waigaoqiao Free Trade Zone, Shanghai (“Novartis”) and Beijing Med-Pharm CorporationEnablex Agreement • March 17th, 2008 • BMP Sunstone CORP • Wholesale-drugs, proprietaries & druggists' sundries
Contract Type FiledMarch 17th, 2008 Company IndustryWhereas, Novartis Pharma AG and its affiliates are the world-wide owner of rights of the product Enablex®, a medication for the treatment of over-active bladder, and markets and sells this product in many countries; and Novartis has the right to develop and Commercialize the product Enablex® in the People’s Republic of China (“PRC”)